483
Andrew Rezvani, M.D.Andrew Rezvani, M.D. – FDA 483, Aug 19, 2022
Record Details
Andrew Rezvani, M.D., a clinical investigator in Palo Alto, CA, was issued a Form 483 following an FDA inspection. The inspection revealed that the firm failed to conduct an investigation in accordance with its investigational plan. Specifically, Serious Adverse Events (SAEs) and their required follow-up information were not reported to the Sponsor in a timely fashion as mandated by the study protocol.
View Company Profile
ID · 7e5e7165-fda9-4556-a4d8-e18b50da7aa3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.